STERIS plc (Ireland) ($STE) Stock Forecast: Up 0.9% Today

What is STERIS plc (Ireland)?

STERIS plc (STE) is a medical equipment provider that has recently seen an increase in institutional investor activity and announced positive financial results, including a dividend declaration.

Why is STERIS plc (Ireland) going up?

STE stock is up 0.9% on Feb 25, 2026 16:42

• The bullish movement in STERIS plc (STE) stock today can be attributed to a combination of factors:
• Strong financial performance: STERIS reported a significant year-over-year revenue increase in Q3, along with positive earnings per share and the issuance of FY2026 guidance, indicating a healthy financial outlook.
• Institutional investor activity: The increase in stake by Dana Investment Advisors Inc. and the continued interest from Generation Investment Management LLP signal confidence in the company's future prospects.
• Industry growth potential: The projected growth in the Japan Hospital Drug Waste Management Market, where STERIS operates, suggests a favorable market environment with opportunities for expansion and revenue growth.
• Analyst sentiment: Despite recent stock price fluctuations, analysts maintain a "Moderate Buy" rating on STERIS with a target price above the current valuation, indicating positive expectations for the stock's performance.

STE Price Chart

STE Technical Analysis

STE News

What To Expect From Solventum's (SOLV) Q4 Earnings

Solventum (NYSE:SOLV) is set to report its Q4 earnings tomorrow afternoon, with analysts expecting a 5.5% year-on-year revenue decline, reversing last year's increase. Despite a history of exceeding expectations, the stock is down 5.6% over the last month, compared to a 1.9% average decline for its peers in the surgical equipment & consumables - diversified segment. Investors will be watching closely after the company beat revenue and EPS expectations last quarter.

https://finviz.com/news/321403/what-to-expect-from-solventums-solv-q4-earnings

Needham Maintains Steris PLC(STE.US) With Hold Rating

Needham analyst Michael Matson has maintained a Hold rating on Steris PLC (STE.US). Matson's past year's performance shows a 43.3% success rate and an average return of 1.0% according to TipRanks data, which independently assesses financial analysts' recommendations. This information is intended for informational purposes only and does not constitute investment advice.

https://news.futunn.com/en/post/68494771/needham-maintains-steris-plc-steus-with-hold-rating

STERIS plc $STE Shares Sold by Generation Investment Management LLP

Generation Investment Management LLP decreased its stake in STERIS plc (NYSE:STE) by 5.9% during the third quarter, selling 185,778 shares, though STERIS remains its 8th largest holding. Other institutional investors also adjusted their positions in the medical equipment provider. STERIS announced a quarterly dividend of $0.63 per share and analysts have given the stock an average rating of "Moderate Buy" with a target price of $275.20.

https://www.marketbeat.com/instant-alerts/filing-steris-plc-ste-shares-sold-by-generation-investment-management-llp-2026-02-24/

STERIS plc $STE Shares Bought by Dana Investment Advisors Inc.

Dana Investment Advisors Inc. significantly increased its stake in STERIS plc (NYSE: STE) by 688.7% in Q3, now holding 44,712 shares valued at $11.063 million. Institutional investors collectively own 94.69% of STERIS. The company reported Q3 EPS of $2.53 and a 9.2% year-over-year revenue increase, issued FY2026 guidance, and declared a $0.63 quarterly dividend.

https://www.marketbeat.com/instant-alerts/filing-steris-plc-ste-shares-bought-by-dana-investment-advisors-inc-2026-02-24/

Japan Hospital Drug Waste Management Market to Reach US$570.7

The Japan Hospital Drug Waste Management Market is projected to grow from US$243.6 Million in 2024 to US$570.7 Million by 2033, exhibiting a CAGR of 9.8% from 2026 to 2033. This growth is driven by regulatory changes, an aging population, rising cancer rates, and technological advancements in waste management. Key players in the market include Stericycle, Veolia, and Waste Management, Inc., with a focus on off-site treatment and various disposal methods.

https://www.openpr.com/news/4401542/japan-hospital-drug-waste-management-market-to-reach-us-570-7

Trending Today

Heating Oil ($HEATOIL) Commodity Forecast: Up 5.5% Today

Brent Crude Oil ($BRENT) Commodity Forecast: Down 2.9% Today

Crude Oil ($CRUDE) Commodity Forecast: Down 3.3% Today

Silver ($XAG) Commodity Forecast: Up 6.4% Today

STERIS plc (Ireland) Price History

25.01.2026 - STE Stock was up 1.0%

• The bullish movement in STE's stock price could be attributed to the positive outlook for the NPWT market. Given the projected significant growth of the global NPWT market due to increasing demand for advanced wound healing technologies, investors might view STE as well-positioned to benefit from this trend.
• The suggestion that STE is a better investment option compared to Abbott Laboratories could have also boosted investor confidence in the company's growth potential and valuation.
• Overall, the combination of favorable market dynamics in the NPWT sector and comparative analysis against peers like ABT might have driven the bullish movement in STE's stock price today.

25.01.2026 - STE Stock was up 0.9%

• The bullish movement in STERIS plc (STE) stock today can be attributed to a combination of factors:
• Strong financial performance: STERIS reported a significant year-over-year revenue increase in Q3, along with positive earnings per share and the issuance of FY2026 guidance, indicating a healthy financial outlook.
• Institutional investor activity: The increase in stake by Dana Investment Advisors Inc. and the continued interest from Generation Investment Management LLP signal confidence in the company's future prospects.
• Industry growth potential: The projected growth in the Japan Hospital Drug Waste Management Market, where STERIS operates, suggests a favorable market environment with opportunities for expansion and revenue growth.
• Analyst sentiment: Despite recent stock price fluctuations, analysts maintain a "Moderate Buy" rating on STERIS with a target price above the current valuation, indicating positive expectations for the stock's performance.

15.04.2025 - STE Stock was up 8.7%

• STE exceeded Q4 earnings expectations, with increased margins, leading to a rise in the stock price.
• The strong growth in Healthcare and AST revenues played a crucial role in the market's positive response.
• Beating earnings estimates by a notable margin and surprising revenue figures indicated the company's strong performance and potential growth.
• Positive analyst projections and key metrics for STE's Q4 earnings reinforced investor confidence in the stock.

05.01.2026 - STE Stock was down 8.5%

• Despite exceeding revenue forecasts and demonstrating robust revenue growth, STERIS witnessed a downward trend in its stock performance.
• The stock's decline could potentially be linked to a slight slowdown in projected revenue growth, raising investor concerns about future prospects.
• Additionally, challenges related to increased tariff pressures may have further dampened investor confidence in the stock's outlook.
• In summary, STERIS continues to uphold a positive market sentiment and strong operational performance. Nevertheless, external factors such as tariff-related uncertainties and growth deceleration might have influenced the recent bearish movement in the stock price.

05.01.2026 - STE Stock was down 8.6%

• Despite reporting strong revenue growth and meeting bottom-line consensus estimates, STE's stock dipped in after-market trading due to investor concerns over the contraction in gross margins.
• The reaffirmation of a Market Outperform rating and a $280.00 price target post the earnings report indicates a positive outlook on STE's performance, but this might not have been enough to offset the margin contraction worries.
• A Hold rating maintained by an analyst could have also contributed to the bearish movement, as it may have raised doubts among investors about the company's future growth potential.
• The slight deceleration in projected revenue growth, despite strong sales performance and operating margin growth, could have added to the negative sentiment surrounding STE's stock today.

15.04.2025 - STE Stock was up 5.2%

• Steris (STE) outperformed earnings expectations in the fourth quarter, demonstrating robust financial performance.
• Projections from analysts on key metrics suggest a positive trajectory for Steris, bolstering investor confidence.
• Strong financial results exceeding estimates and optimistic analyst forecasts likely fueled today's bullish movement in Steris (STE) stock.
• The company’s solid performance and growth potential may be prompting investors to increase buying activity, consequently driving up the stock price.

07.07.2025 - STE Stock was up 5.9%

• Steris (STE) reported better-than-expected Q1 earnings and revenue, indicating strong financial performance.
• The announcement of a new Chief Financial Officer may have instilled confidence in investors about the company's future leadership and strategic direction.
• Analysts are optimistic about Steris' key performance measures, particularly in the Healthcare and Applied Sterilization Technologies segments, which are expected to drive growth.
• The focus on Healthcare growth and anticipated EPS growth of 14.3% further bolstered investor sentiment, contributing to the bullish movement in the stock price.

07.07.2025 - STE Stock was up 6.5%

• STE experienced a strong bullish movement today, likely in response to the positive Q1 earnings performance.
• The company exceeded both earnings and revenue expectations, showcasing a 15% growth in EPS and an upgraded FY26 revenue projection.
• The recent appointment of a new Chief Financial Officer may have also influenced investor sentiment in a favorable manner.
• Analysts hold an optimistic outlook on STE, particularly in the healthcare industry, foreseeing continued growth and the possibility of more positive earnings surprises in the future.

07.10.2024 - STE Stock was down 6.1%

• Despite surpassing earnings expectations in Q2, STE observed a downward trend in its stock price, possibly influenced by worries about margin reduction.
• The market's negative response to the margin decline contrasts with the solid revenue expansion in the Healthcare and AST segments.
• Investor sentiment towards the company's outlook appears cautious, as indicated by queries about future stock performance.

28.09.2025 - STE Stock was down 1.4%

• The decline in STE stock today could be linked to the following factors:
• Investor caution ahead of the upcoming Q2 earnings.
• Potential apprehensions about the company's performance in the current quarter.
• The market reacting to the announcement of a conference call to review fiscal 2026 second quarter results.

06.10.2025 - STE Stock was up 6.6%

• STE stock saw significant bullish activity today.
• Surpassing Q2 earnings and revenue projections signals robust financial results for the company.
• A noteworthy 10% rise in total revenue for the second quarter of fiscal 2026 highlights favorable growth prospects.
• Positive sentiments from analysts and investors regarding STE's future performance are bolstering investor trust in the stock.

05.00.2026 - STE Stock was up 2.2%

• Harvey Investment Co. LLC increasing its stake in STERIS plc by 17.1% indicates confidence in the company's future growth prospects, contributing to the bullish movement.
• The positive sentiment from analysts and institutional investors, coupled with STERIS exceeding earnings estimates and providing strong guidance, likely boosted investor confidence in the stock.
• While Pacer Advisors Inc. reducing its stake may have initially caused some selling pressure, the overall market sentiment remained positive due to the company's solid financial performance and essential services in the healthcare sector.
• STERIS's stability and long-term growth potential positioned the stock as an attractive option for investors seeking reliability amidst market volatility, further supporting its bullish movement.